federal_register: 2014-10933

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2014-10933 Immune Responses to Enzyme Replacement Therapies: Role of Immune Tolerance Induction; Public Workshop Notice The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, in cosponsorship with the National Organization for Rare Disorders (NORD), is announcing a 1-day public workshop entitled "Immune Responses to Enzyme Replacement Therapies: Role of Immune Tolerance Induction." Partners and stakeholders planning the workshop also include representatives from academia, industry, and patients. The purpose of this workshop is to provide a forum to discuss the role of immune tolerance induction in patients receiving replacement biological products. 2014-05-13 2014 5 https://www.federalregister.gov/documents/2014/05/13/2014-10933/immune-responses-to-enzyme-replacement-therapies-role-of-immune-tolerance-induction-public-workshop https://www.govinfo.gov/content/pkg/FR-2014-05-13/pdf/2014-10933.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, in cosponsorship with the National Organization for Rare Disorders (NORD), is announcing a 1-day public workshop entitled "Immune Responses to Enzyme Replacement...  

Links from other tables